Dan‐Ping Xu

596 total citations
25 papers, 492 citations indexed

About

Dan‐Ping Xu is a scholar working on Immunology, Agronomy and Crop Science and Obstetrics and Gynecology. According to data from OpenAlex, Dan‐Ping Xu has authored 25 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 6 papers in Agronomy and Crop Science and 5 papers in Obstetrics and Gynecology. Recurrent topics in Dan‐Ping Xu's work include Reproductive System and Pregnancy (16 papers), Immune Cell Function and Interaction (7 papers) and Reproductive Physiology in Livestock (6 papers). Dan‐Ping Xu is often cited by papers focused on Reproductive System and Pregnancy (16 papers), Immune Cell Function and Interaction (7 papers) and Reproductive Physiology in Livestock (6 papers). Dan‐Ping Xu collaborates with scholars based in China, Thailand and United States. Dan‐Ping Xu's co-authors include Wei‐Hua Yan, Aifen Lin, Yanyun Ruan, Huihui Xu, Xia Zhang, Qing Wang, Baoguo Chen, Wenjun Zhou, Xia Zhang and Xiaoqun Zheng and has published in prestigious journals such as International Journal of Cancer, Frontiers in Immunology and Journal of Ethnopharmacology.

In The Last Decade

Dan‐Ping Xu

25 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan‐Ping Xu China 14 408 127 105 83 69 25 492
K. Marzusch Germany 14 366 0.9× 179 1.4× 133 1.3× 45 0.5× 18 0.3× 32 564
S.C. Shorter United Kingdom 7 388 1.0× 131 1.0× 138 1.3× 63 0.8× 20 0.3× 14 481
M Goluda Poland 10 86 0.2× 147 1.2× 34 0.3× 8 0.1× 35 0.5× 27 282
Vivian Wu Canada 7 104 0.3× 26 0.2× 73 0.7× 8 0.1× 33 0.5× 12 522
P. Ide Belgium 13 129 0.3× 251 2.0× 42 0.4× 7 0.1× 62 0.9× 19 563
Alamtaj Samsami Dehaghani Iran 14 216 0.5× 63 0.5× 55 0.5× 2 0.0× 156 2.3× 38 516
Katsuo Yoshida Japan 7 172 0.4× 18 0.1× 22 0.2× 4 0.0× 70 1.0× 9 353
Anne M. Stevens United States 11 272 0.7× 7 0.1× 32 0.3× 4 0.0× 70 1.0× 15 424
Sabrina Zidi Tunisia 12 119 0.3× 32 0.3× 10 0.1× 3 0.0× 57 0.8× 29 311
Sami B. Kanaan United States 12 142 0.3× 11 0.1× 38 0.4× 2 0.0× 31 0.4× 35 338

Countries citing papers authored by Dan‐Ping Xu

Since Specialization
Citations

This map shows the geographic impact of Dan‐Ping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan‐Ping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan‐Ping Xu more than expected).

Fields of papers citing papers by Dan‐Ping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan‐Ping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan‐Ping Xu. The network helps show where Dan‐Ping Xu may publish in the future.

Co-authorship network of co-authors of Dan‐Ping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan‐Ping Xu. A scholar is included among the top collaborators of Dan‐Ping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan‐Ping Xu. Dan‐Ping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Pei, Zifei Qin, Xinya Zhang, et al.. (2025). Deciphering the effective components of a TCM formula for atherosclerosis by three-dimensional pattern recognition of exogenous components correlated with endogenous metabolites. Journal of Ethnopharmacology. 346. 119647–119647. 1 indexed citations
3.
Xu, Huihui, Jun Gan, Dan‐Ping Xu, Lu Li, & Wei‐Hua Yan. (2021). Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers. Frontiers in Immunology. 12. 614773–614773. 13 indexed citations
4.
Xu, Dan‐Ping, et al.. (2021). Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester. Frontiers in Genetics. 11. 497264–497264. 1 indexed citations
5.
Sun, Liping, et al.. (2020). [Pregnancy with pre-excitation syndrome influence on pregnancy outcomes].. PubMed. 55(10). 685–690. 1 indexed citations
6.
Xu, Dan‐Ping, et al.. (2017). HLA-G 14 bp insertion/deletion polymorphism is a prognostic factor for non-small-cell lung cancer. Zhonghua weishengwuxue he mianyixue zazhi. 37(5). 361–368. 1 indexed citations
7.
Xu, Dan‐Ping, et al.. (2014). Associations Between Epidermal Growth Factor Receptor Gene Mutation and Serum Tumor Markers in Advanced Lung Adenocarcinomas: A Retrospective Study. Chinese Medical Sciences Journal. 29(3). 156–161. 2 indexed citations
8.
Zhang, Weiqun, Dan‐Ping Xu, Di Liu, et al.. (2013). HLA-G1 and HLA-G5 isoforms have an additive effect on NK cytolysis. Human Immunology. 75(2). 182–189. 22 indexed citations
9.
Zheng, Xiaoqun, Xiaohong Chen, Yan Gao, et al.. (2013). Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71. Clinical and Experimental Medicine. 14(2). 161–167. 13 indexed citations
10.
Lin, Aifen, Huihui Xu, Dan‐Ping Xu, et al.. (2012). Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression. Human Immunology. 74(4). 439–446. 45 indexed citations
11.
Chen, Baoguo, Dan‐Ping Xu, Aifen Lin, & Wei‐Hua Yan. (2012). NK cytolysis is dependent on the proportion of HLA-G expression. Human Immunology. 74(3). 286–289. 31 indexed citations
12.
Xu, Dan‐Ping, et al.. (2011). Elevation of plasma soluble human leukocyte antigen–G in patients with chronic hepatitis C virus infection. Human Immunology. 72(5). 406–411. 38 indexed citations
13.
Lin, Aifen, Xia Zhang, Huihui Xu, et al.. (2011). HLA‐G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer. International Journal of Cancer. 131(1). 150–157. 38 indexed citations
14.
Lin, Aifen, Dan‐Ping Xu, Jiangang Zhang, et al.. (2011). Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection. Human Immunology. 72(11). 1068–1073. 27 indexed citations
15.
Gan, Lixia, et al.. (2010). Polymorphism of human CD1a, CD1d, and CD1e in exon 2 in Chinese Han and She ethnic populations. Tissue Antigens. 75(6). 691–695. 8 indexed citations
16.
Dai, Mei, Yangxun Pan, Dan‐Ping Xu, et al.. (2010). IL‐1 receptor antagonist gene polymorphism in idiopathic recurrent spontaneous abortion in a Chinese Han population. International Journal of Immunogenetics. 37(5). 393–396. 10 indexed citations
17.
Lin, Aifen, Xia Zhang, Wenjun Zhou, et al.. (2010). Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. International Journal of Cancer. 129(6). 1382–1390. 53 indexed citations
18.
Zhang, Xia, Aifen Lin, Dan‐Ping Xu, et al.. (2010). Tumor-specific upregulation of human leukocyte antigen–G expression in bladder transitional cell carcinoma. Human Immunology. 71(9). 899–904. 21 indexed citations
19.
Zheng, Xiaoqun, et al.. (2010). Analysis of the plasma soluble human leukocyte antigen–G and interleukin-10 levels in childhood atopic asthma. Human Immunology. 71(10). 982–987. 38 indexed citations
20.
Lin, Aifen, et al.. (2009). Ethnic variation of the HLA‐G*0105N allele in two Chinese populations. Tissue Antigens. 73(3). 270–274. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026